SAMANTHA HOOD: Open Payments
NPI 1578189080 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 39 payments from 15 companies in 2025. Trend: 2023 $479 · 2024 $727 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $111 |
| CVRx, Inc. | 3 | $88 |
| Alnylam Pharmaceuticals Inc. | 3 | $87 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| PFIZER INC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Novo Nordisk Inc | 2 | $46 |
Products named: Barostim Neo System, ONPATTRO, VERQUVO, LifeVest, LEQVIO, Kerendia, VYNDAQEL, FARXIGA.
Industry payments across LA — which companies pay providers there.
